Imagion Biosystems today announced “Notice of change of interests of substantial holder — IBX.”
View Form 604 Notice of change of interests of substantial holder — IBX.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the